Streetbeat News

Revenues

LFLY

Leafly Holdings reported an expected Q2 revenue of approximately $8.6 million, slightly below the estimated $8.683 million, with an adjusted EBITDA loss of $1.1 million.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:23 pm

HAYN

Haynes International (HAYN) anticipates higher revenue and earnings in Q3 compared to Q2 of fiscal 2024, signaling potential growth.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:23 pm

ARLO

Arlo Technologies projects its Q2 2024 adjusted EPS to be between $0.06 and $0.12, compared to the estimated $0.09. The company also forecasts revenue to be in the range of $120M to $130M, versus the estimated $124.701M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:22 pm

SST

System1 anticipates Q2 revenue to be between $88M-$90M, slightly below the estimated $90.298M. The company also projects a gross profit of $20M-$22M, adjusted gross profit of $33M-$35M, and adjusted EBITDA of $5M-$7M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:21 pm

INDI

indie Semiconductor projects its Q2 2024 revenue to range from flat to a 5% increase sequentially, aiming to counteract market softness due to ongoing industry-wide inventory rebalancing. CFO Thomas Schiller also anticipates gross margin expansion to 51-52% and a narrower operating loss, attributed to a richer product mix and flat expenses.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:19 pm

PROF

Profound Medical projects its FY24 revenue to be between $11M and $12M, which is in line with the analyst estimate of $11.635M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:19 pm

OSS

One Stop Systems (OSS) anticipates its Q2 revenue to be around $13M, which is below the estimated $13.579M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:18 pm

SUZ

Suzano reported a 16% year-over-year decline in Q1 net revenue to R$9.459 billion, and a 96% decrease in net income.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:17 pm

ADMA

ADMA Biologics projects its FY25 revenue to exceed $410 million, surpassing the estimated $389.875 million. This forecast suggests a positive outlook for the company's financial growth.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:15 pm

ADMA

ADMA Biologics projects its FY24 revenue to exceed $355 million, surpassing the estimated $333.875 million. This forecast suggests a positive outlook for the company's financial performance in the upcoming fiscal year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:15 pm